Perkins Capital Management Inc. Cuts Position in ANI Pharmaceuticals Inc (ANIP)

Perkins Capital Management Inc. trimmed its position in ANI Pharmaceuticals Inc (NASDAQ:ANIP) by 0.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,550 shares of the specialty pharmaceutical company’s stock after selling 150 shares during the period. ANI Pharmaceuticals accounts for approximately 1.5% of Perkins Capital Management Inc.’s investment portfolio, making the stock its 18th biggest holding. Perkins Capital Management Inc. owned about 0.27% of ANI Pharmaceuticals worth $2,296,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Mesirow Financial Investment Management Inc. increased its position in shares of ANI Pharmaceuticals by 46.8% in the 1st quarter. Mesirow Financial Investment Management Inc. now owns 10,315 shares of the specialty pharmaceutical company’s stock valued at $728,000 after acquiring an additional 3,288 shares during the period. Renaissance Technologies LLC grew its position in ANI Pharmaceuticals by 2.9% during the 3rd quarter.